2015
DOI: 10.1016/j.clp.2015.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Copy Number Variants, Aneuploidies, and Human Disease

Abstract: In the perinatal setting, chromosome imbalances cause a wide range of clinically significant disorders and increase risk for other particular phenotypes. As technologies have improved to detect increasingly smaller deletions and duplications, collectively referred to as copy number variants (CNVs), we are learning the significant role that these types of genomic variants play in human disease and their relatively high frequency in ~1% of all pregnancies. In this overview, we will highlight key aspects of CNV d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
51
0
6

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(57 citation statements)
references
References 41 publications
0
51
0
6
Order By: Relevance
“…Consequently, the identification of an underlying genetic etiology in patients with ID, ASD and MCA has significantly increased due to the application of CNV microarrays [20,71]. The impact of establishing a genetic diagnosis in congenital disorders is significant as it allows appropriate referrals for therapy, surveillance for potential future involvement of other tissues and organs and assist in better genetic counseling for the family [65].…”
Section: The Evolution Of Cnv Detection Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Consequently, the identification of an underlying genetic etiology in patients with ID, ASD and MCA has significantly increased due to the application of CNV microarrays [20,71]. The impact of establishing a genetic diagnosis in congenital disorders is significant as it allows appropriate referrals for therapy, surveillance for potential future involvement of other tissues and organs and assist in better genetic counseling for the family [65].…”
Section: The Evolution Of Cnv Detection Methodsmentioning
confidence: 99%
“…CNV analysis with microarrays is offered as routine clinical test, with the results being increasingly used in genetic counseling and clinical management [71]. However, the ability to detect CNVs using high throughput technologies has far outpaced the ability to determine their role in disease pathogenesis.…”
Section: Challenges In Cnv Association To Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…CMA's increased yield over traditional karyotyping (Crolla et al 2014; Wapner et al, 2012) led the American College of Obstetrics and Gynecology (ACOG) to recommend prenatal CMA testing be considered a first tier test following detection of an ultrasound anomaly, and made available when performing invasive genetic testing for any indication including maternal age (American College of Obstetricians and Gynecologist 2013). The increased diagnostic yield of CMA is, however, accompanied by the possibility of finding CNVs of uncertain clinical significance (VUS), incomplete penetrance, or variable expressivity (Martin et al 2015) with a wide range of associated phenotypes ranging from apparently normal to severely affected.…”
Section: Introductionmentioning
confidence: 99%
“…For example, copynumber variants resulting from the reciprocal deletion and duplication products of nonallelic recombination are associated with dozens of recurrent human disorders (Stankiewicz and Lupski 2002;Shaw and Lupski 2004;Sharp et al 2005;Turner et al 2008;Abyzov et al 2015;Martin et al 2015). These include hereditary neuropathy with liability to pressure palsies and Charcot-Marie -Tooth disease type 1A (Chance et al 1994), Prader-Willi syndrome/ Angelman syndrome and 15q11q13 duplication (Long et al 1998), velocardiofacial syndrome and dup22(q11.2q11.2) (Edelmann et al 1999a), Smith -Magenis syndrome and Potocki -Lupski syndrome (Potocki et al 2000), and Williams -Beuren syndrome and dup7 (q11.23) (Somerville et al 2005).…”
Section: Meiotic Recombination and Genomic Disordersmentioning
confidence: 99%